ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2020$120,000
-84.4%
15,165
-85.2%
0.00%
-100.0%
Q4 2019$771,000
+970.8%
102,171
+771.5%
0.00%
Q2 2018$72,000
-65.7%
11,724
-41.4%
0.00%
-100.0%
Q3 2017$210,000
+16.0%
20,000
+22.0%
0.00%0.0%
Q2 2017$181,00016,4000.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2017
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,102,673$4,468,0000.92%
JW Asset Management, LLC 444,439$640,0000.33%
BRANDES INVESTMENT PARTNERS, LP 7,052,720$10,157,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,722,241$3,920,0000.15%
Tekla Capital Management LLC 814,588$1,173,0000.05%
INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV 34,750$50,0000.04%
Brown Capital Management 1,400,007$2,016,0000.02%
ACADIAN ASSET MANAGEMENT LLC 843,975$1,217,0000.01%
WEDBUSH SECURITIES INC 35,535$51,0000.01%
Close Asset Management Ltd 15,000$22,0000.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders